Home > Category > Signaling Pathways > Endocrinology & Hormones > Estrogen/progestogen Receptor > 4-Hydroxytamoxifen | (Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen;(Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol

4-Hydroxytamoxifen | (Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen;(Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol

ChemLeader 98+%

Catalog No：CL1009 CAS No.：68047-06-3 MDLNo： Formula：C26H29NO2 MW：387.52

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	In-stock	$180.00	Visible after login	- +
10 mg	In-stock	$300.00	Visible after login	- +
25 mg	In-stock	$580.00	Visible after login	- +
50 mg	In-stock	$1000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	4-Hydroxytamoxifen \| (Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen;(Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol
CAS	68047-06-3
Formula	C26H29NO2
MW	387.52
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) is an orally active, selective estrogen receptor modulator (SERM). 4-Hydroxytamoxifen ((Z)-4-Hydroxytamoxifen) induces CRISPR/Cas9 systems based on ER mediated nucleus translocation.

Related literature

Sorry, there is no relevant literature

CL1009A

(E)-4-Hydroxytamoxifen; (E)-Afimoxifene

174592-47-3 97%

History

CL1009

4-Hydroxytamoxifen | (Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen;(Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol

68047-06-3 98+%